Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for diabetic patients with diastolic heart failure
IRCT20141209020258N69Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of metformin in heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Arak University of Medical Sciences. Started Oct 2017; status: completed.
02
Drugs
metformin
03
Conditions
heart failure with preserved ejection fraction (HFpEF)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20141209020258N69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N69.